REFERENCES
1. Crawford ES, De Bakey ME, Colley DA. Clinical use of synthetic arterial substitutes in three hundred seventeen patients. AMA Arch Surg 1958;76:261-70.
2. Carter SC, Cohen A, Whelan TJ. Clinical experience with management of the infected dacron graft. Ann Surg 1963;158:249-55.
3. Habib G, Lancellotti P, Antunes MJ, et al. ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: the Task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075-128.
4. Chakfé N, Diener H, Lejay A, et al. Editor’s choice - European Society for Vascular Surgery (ESVS) 2020 clinical practice guidelines on the management of vascular graft and endograft infections. Eur J Vasc Endovasc Surg 2020;59:339-84.
5. Wilson WR, Bower TC, Creager MA, et al. American Heart Association Committee on Rheumatic Fever. Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American Heart Association. Circulation 2016;134:e412-60.
6. Luehr M, Peterss S, Zierer A, et al. Aortic events and reoperations after elective arch surgery: incidence, surgical strategies and outcomes. Eur J Cardiothorac Surg 2018;53:519-24.
7. Vikholm P, Astudillo R, Thelin S. Long-term survival and frequency of reinterventions after proximal aortic surgery: a retrospective study†. Eur J Cardiothorac Surg 2019;56:722-30.
8. Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg 2008;47:264-9.
9. Shiraev T, Barrett S, Heywood S, et al. Incidence, management, and outcomes of aortic graft infection. Ann Vasc Surg 2019;59:73-83.
10. Berger P, Vaartjes I, Moll FL, De Borst GJ, Blankensteijn JD, Bots ML. Cumulative incidence of graft infection after primary prosthetic aortic reconstruction in the endovascular era. Eur J Vasc Endovasc Surg 2015;49:581-5.
11. Langenberg JCM, Kluytmans JAJW, de Groot HGW, et al. Surgical site and graft infections in endovascular and open abdominal aortic aneurysm surgery. Surg Infect (Larchmt) 2018;19:424-9.
13. Anagnostopoulos A, Ledergerber B, Kuster SP, et al. VASGRA Cohort Study. Inadequate perioperative prophylaxis and postsurgical complications after graft implantation are important risk factors for subsequent vascular graft infections: prospective results from the vascular graft infection cohort study. Clin Infect Dis 2019;69:621-30.
14. Hasse B, Husmann L, Zinkernagel A, Weber R, Lachat M, Mayer D. Vascular graft infections. Swiss Med Wkly 2013;143:w13754.
15. Oda T, Minatoya K, Kobayashi J, et al. Prosthetic vascular graft infection through a median sternotomy: a multicentre review †. Interact Cardiovasc Thorac Surg 2015;20:701-6; discussion 706.
16. Kohler P, Kuster SP, Bloemberg G, et al. Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminated Mycobacterium chimaera infections subsequent to open heart surgery. Eur Heart J 2015;36:2745-53.
17. Revest M, Camou F, Senneville E, et al. Groupe de Réflexion sur les Infections de Prothèses vasculaires (GRIP). Medical treatment of prosthetic vascular graft infections: review of the literature and proposals of a Working Group. Int J Antimicrob Agents 2015;46:254-65.
18. Ramos A, García-Montero C, Moreno A, et al. Endocarditis in patients with ascending aortic prosthetic graft: a case series from a national multicentre registry. Eur J Cardiothorac Surg 2016;50:1149-57.
19. Shah DK, Li Z, Park SJ, et al. Replacement of the infected composite aortic root prosthesis. Ann Thorac Surg 2011;92:1651-5.
20. Hostalrich A, Ozdemir BA, Sfeir J, Solovei L, Alric P, Canaud L. Systematic review of native and graft-related aortic infection outcome managed with orthotopic xenopericardial grafts. J Vasc Surg 2019;69:614-8.
21. Coselli JS, Köksoy C, Lemaire SA. Management of thoracic aortic graft infections. Ann Thorac Surg 1999;67:1990-3.
22. LeMaire SA, Coselli JS. Options for managing infected ascending aortic grafts. J Thorac Cardiovasc Surg 2007;134:839-43.
23. Takano T, Terasaki T, Wada Y, Seto T, Fukui D, Amano J. Treatment of prosthetic graft infection after thoracic aorta replacement. Ann Thorac Cardiovasc Surg 2014;20:304-9.
24. FitzGerald SF, Kelly C, Humphreys H. Diagnosis and treatment of prosthetic aortic graft infections: confusion and inconsistency in the absence of evidence or consensus. J Antimicrob Chemother 2005;56:996-9.
25. Szilagyi DE, Smith RF, Elliott JP, Vrandecic MP. Infection in arterial reconstruction with synthetic grafts. Ann Surg 1972;176:321-33.
26. Samson RH, Veith FJ, Janko GS, Gupta SK, Scher LA. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J Vasc Surg 1988;8:147-153.
28. Mayer D, Hasse B, Koelliker J, et al. Long-term results of vascular graft and artery preserving treatment with negative pressure wound therapy in Szilagyi grade III infections justify a paradigm shift. Ann Surg 2011;254:754-59; discussion 760.
29. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.
30. Lyons OT, Baguneid M, Barwick TD, et al. Diagnosis of aortic graft infection: a case definition by the Management of Aortic Graft Infection Collaboration (MAGIC). Eur J Vasc Endovasc Surg 2016;52:758-63.
31. Anagnostopoulos A, Mayer F, Ledergerber B, et al. VASGRA Cohort Study. Editor's choice - validation of the Management of Aortic Graft Infection Collaboration (MAGIC) criteria for the diagnosis of vascular graft/endograft infection: results from the prospective vascular graft cohort study. Eur J Vasc Endovasc Surg 2021;62:251-7.
32. Reinders Folmer EI, Von Meijenfeldt GCI, Van der Laan MJ, et al. Diagnostic imaging in vascular graft infection: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2018;56:719-29.
33. Lauri C, Iezzi R, Rossi M, et al. Imaging modalities for the diagnosis of vascular graft infections: a consensus paper amongst different specialists. J Clin Med 2020;9:1510.
34. Shahidi S, Eskil A, Lundof E, Klaerke A, Jensen BS. Detection of abdominal aortic graft infection: comparison of magnetic resonance imaging and indium-labeled white blood cell scanning. Ann Vasc Surg 2007;21:586-92.
35. Khaja MS, Sildiroglu O, Hagspiel K, Rehm PK, Cherry KJ, Turba UC. Prosthetic vascular graft infection imaging. Clin Imaging 2013;37:239-44.
36. Annovazzi A, Bagni B, Burroni L, D'Alessandria C, Signore A. Nuclear medicine imaging of inflammatory/infective disorders of the abdomen. Nucl Med Commun 2005;26:657-64.
37. Jamar F, Buscombe J, Chiti A, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med 2013;54:647-58.
38. Bruggink JL, Slart RH, Pol JA, Reijnen MM, Zeebregts CJ. Current role of imaging in diagnosing aortic graft infections. Semin Vasc Surg 2011;24:182-90.
39. Kim SJ, Lee SW, Jeong SY, Pak K, Kim K. A systematic review and meta-analysis of 18F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography for detection of infected prosthetic vascular grafts. J Vasc Surg 2019;70:307-13.
40. Tokuda Y, Oshima H, Araki Y, et al. Detection of thoracic aortic prosthetic graft infection with 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Eur J Cardiothorac Surg 2013;43:1183-7.
41. Reinders Folmer EI, von Meijenfeldt GCI, Te Riet Ook Genaamd Scholten RS, et al. A systematic review and meta-analysis of 18F-fluoro-d-deoxyglucose positron emission tomography interpretation methods in vascular graft and endograft infection. J Vasc Surg 2020;72:2174-2185.e2.
42. Saleem BR, Pol RA, Slart RH, Reijnen MM, Zeebregts CJ. 18F-Fluorodeoxyglucose positron emission tomography/CT scanning in diagnosing vascular prosthetic graft infection. Biomed Res Int 2014;2014:471971.
43. Berger P, Vaartjes I, Scholtens A, et al. Differential FDG-PET uptake patterns in uninfected and infected central prosthetic vascular grafts. Eur J Vasc Endovasc Surg 2015;50:376-83.
44. Mitra A, Pencharz D, Davis M, Wagner T. Determining the diagnostic value of 18F-fluorodeoxyglucose positron emission/computed tomography in detecting prosthetic aortic graft infection. Ann Vasc Surg 2018;53:78-85.
45. Husmann L, Ledergerber B, Anagnostopoulos A, et al. VASGRA Cohort Study. The role of FDG PET/CT in therapy control of aortic graft infection. Eur J Nucl Med Mol Imaging 2018;45:1987-97.
46. Ajdler-Schaeffler E, Scherrer AU, Keller PM, et al. and the VASGRA Cohort. Increased pathogen identification in vascular graft infections by the combined use of tissue cultures and 16S rRNA gene polymerase chain reaction. Front Med (Lausanne) 2018;5:169.
47. Scherrer AU, Bloemberg G, Zbinden R, et al. VASGRA Cohort. Prosthetic vascular graft infections: bacterial cultures from negative-pressure-wound-therapy foams do not improve diagnostics. J Clin Microbiol 2016;54:2190-3.
48. Kokosar Ulcar B, Lakic N, Jeverica S, et al. Contribution of sonicate-fluid cultures and broad-range PCR to microbiological diagnosis in vascular graft infections. Infect Dis (Lond) 2018;50:429-35.
49. Moulakakis KG, Mylonas SN, Antonopoulos CN, et al. Comparison of treatment strategies for thoracic endograft infection. J Vasc Surg 2014;60:1061-71.
50. Lyons OT, Patel AS, Saha P, Clough RE, Price N, Taylor PR. A 14-year experience with aortic endograft infection: management and results. Eur J Vasc Endovasc Surg 2013;46:306-13.
52. Akowuah E, Narayan P, Angelini G, Bryan AJ. Management of prosthetic graft infection after surgery of the thoracic aorta: removal of the prosthetic graft is not necessary. J Thorac Cardiovasc Surg 2007;134:1051-2.
53. Hart JP, Eginton MT, Brown KR, et al. Operative strategies in aortic graft infections: is complete graft excision always necessary? Ann Vasc Surg 2005;19:154-60.
54. Batt M, Jean-Baptiste E, O'Connor S, et al. Early and late results of contemporary management of 37 secondary aortoenteric fistulae. Eur J Vasc Endovasc Surg 2011;41:748-57.
55. Ljungquist O, Dias N, Haidl S, Sonesson B, Sörelius K, Ahl J. Guided aspiration for determining the microbiological aetiology of aortic vascular graft and endograft infections. Eur J Vasc Endovasc Surg 2021;62:935-43.
56. Gavali H, Mani K, Furebring M, et al. Editor's choice - outcome of radical surgical treatment of abdominal aortic graft and endograft infections comparing extra-anatomic bypass with in situ reconstruction: a nationwide multicentre study. Eur J Vasc Endovasc Surg 2021;62:918-26.
57. Oderich GS, Bower TC, Cherry KJ Jr, et al. Evolution from axillofemoral to in situ prosthetic reconstruction for the treatment of aortic graft infections at a single center. J Vasc Surg 2006;43:1166-74.
58. Batt M, Jean-Baptiste E, O'Connor S, Feugier P, Haulon S. Association Universitaire de Recherche en Chirurgie Vasculaire (AURC). Contemporary management of infrarenal aortic graft infection: early and late results in 82 patients. Vascular 2012;20:129-37.
59. Post ICJH, Vos CG. Systematic review and meta-analysis on the management of open abdominal aortic graft infections. Eur J Vasc Endovasc Surg 2019;58:258-81.
60. Kahlberg A, Grandi A, Loschi D, et al. A systematic review of infected descending thoracic aortic grafts and endografts. J Vasc Surg 2019;69:1941-1951.e1.
61. Inoue T, Imura M, Kaneda T, Saga T. Long-term survival after coverage with prevertebral fascia for abdominal aortic stump closure. Vasc Endovascular Surg 2017;51:43-6.
62. Sarac TP, Augustinos P, Lyden S, Ouriel K. Use of fascia-peritoneum patch as a pledget for an infected aortic stump. J Vasc Surg 2003;38:1404-6.
63. Ben Ahmed S, Louvancourt A, Daniel G, et al. Cryopreserved arterial allografts for in situ reconstruction of abdominal aortic native or secondary graft infection. J Vasc Surg 2018;67:468-77.
64. Vogt PR, Rocca HB, Carrel T, et al. Cryopreserved arterial allografts in the treatment of major vascular infection: a comparison with conventional surgical techniques. J Thorac Cardiovasc Surg 1998;116:965-72.
65. Masabni K, Weaver MR, Kandagatla P, et al. Cryopreserved allograft in the management of native and prosthetic aortic infections. Ann Vasc Surg 2019;56:1-10.
66. Harlander-Locke MP, Harmon LK, Lawrence PF, et al. Vascular Low-Frequency Disease Consortium. The use of cryopreserved aortoiliac allograft for aortic reconstruction in the United States. J Vasc Surg 2014;59:669-74.
67. Batt M, Jean-Baptiste E, O'Connor S, et al. In-situ revascularisation for patients with aortic graft infection: a single centre experience with silver coated polyester grafts. Eur J Vasc Endovasc Surg 2008;36:182-8.
68. Kreibich M, Siepe M, Berger T, et al. Treatment of infectious aortic disease with bovine pericardial tube grafts. Eur J Cardiothorac Surg 2021;60:155-61.
69. Carrel T, Englberger L, Schmidli J. How to treat aortic graft infection? Gen Thorac Cardiovasc Surg 2019;67:44-52.
70. Alonso W, Ozdemir B, Chassin-Trubert L, Ziza V, Alric P, Canaud L. Early outcomes of native and graft-related abdominal aortic infection managed with orthotopic xenopericardial grafts. J Vasc Surg 2021;73:222-31.
71. Weiss S, Tobler EL, von Tengg-Kobligk H, et al. Self made Xeno-pericardial aortic tubes to treat native and aortic graft infections. Eur J Vasc Endovasc Surg 2017;54:646-52.
72. Janko MR, Woo K, Hacker RI, et al. In situ bypass and extra-anatomic bypass procedures result in similar survival in patients with secondary aortoenteric fistulas. J Vasc Surg 2021;73:210-221.e1.
73. Chopra A, Cieciura L, Modrall JG, Valentine RJ, Chung J. Twenty-year experience with aorto-enteric fistula repair: gastrointestinal complications predict mortality. J Am Coll Surg 2017;225:9-18.
74. Kakkos SK, Antoniadis PN, Klonaris CN, et al. Open or endovascular repair of aortoenteric fistulas? Eur J Vasc Endovasc Surg 2011;41:625-34.
75. Danneels MI, Verhagen HJ, Teijink JA, Cuypers P, Nevelsteen A, Vermassen FE. Endovascular repair for aorto-enteric fistula: a bridge too far or a bridge to surgery? Eur J Vasc Endovasc Surg 2006;32:27-33.
76. Janko M, Hubbard G, Woo K, et al. Contemporary outcomes after partial resection of infected aortic grafts. Ann Vasc Surg 2021;76:202-10.
77. Hargrove WC, Edmunds LH. Management of infected thoracic aortic prosthetic grafts. Ann Thorac Surg 1984;37:72-7.
78. McKellar SH, Schaff HV, Dearani JA, et al. Intermediate-term results of ascending-descending posterior pericardial bypass of complex aortic coarctation. J Thorac Cardiovasc Surg 2007;133:1504-9.
79. Kieffer E, Sabatier J, Plissonnier D, Knosalla C. Prosthetic graft infection after descending thoracic/ thoracoabdominal aortic aneurysmectomy: management with in situ arterial allografts. J Vasc Surg 2001;33:671-8.
80. Kahlberg A, Melissano G, Mascia D, Loschi D, Grandi A, Chiesa R. How to best treat infectious complications of open and endovascular thoracic aortic repairs. Semin Vasc Surg 2017;30:95-102.
81. Rustum S, Beckmann E, Martens A, et al. Native and prosthetic graft infections of the thoracic aorta: surgical management. Eur J Cardiothorac Surg 2021;60:633-41.
82. Sandhu HK, Nissen AP, Mushtaq H, et al. Resection and replacement of thoracic aortic graft infections. J Thorac Cardiovasc Surg 2021;162:1-8.
83. Chiesa R, Melissano G, Marone EM, Marrocco-Trischitta MM, Kahlberg A. Aorto-oesophageal and aortobronchial fistulae following thoracic endovascular aortic repair: a national survey. Eur J Vasc Endovasc Surg 2010;39:273-9.
84. Czerny M, Eggebrecht H, Sodeck G, et al. New insights regarding the incidence, presentation and treatment options of aorto-oesophageal fistulation after thoracic endovascular aortic repair: the European registry of endovascular aortic repair complications. Eur J Cardiothorac Surg 2014;45:452-7.
85. Czerny M, Reser D, Eggebrecht H, et al. Aorto-bronchial and aorto-pulmonary fistulation after thoracic endovascular aortic repair: an analysis from the European registry of endovascular aortic repair complications. Eur J Cardiothorac Surg 2015;48:252-7.
86. Canaud L, D'Annoville T, Ozdemir BA, Marty-Ané C, Alric P. Combined endovascular and surgical approach for aortobronchial fistula. J Thorac Cardiovasc Surg 2014;148:2108-11.
87. Jonker FH, Schlösser FJ, Moll FL, et al. Outcomes of thoracic endovascular aortic repair for aortobronchial and aortoesophageal fistulas. J Endovasc Ther 2009;16:428-40.
88. Khaladj N, Pichlmaier U, Stachmann A, et al. Cryopreserved human allografts (homografts) for the management of graft infections in the ascending aortic position extending to the arch. Eur J Cardiothorac Surg 2013;43:1170-5.
89. Umminger J, Krueger H, Beckmann E, et al. Management of early graft infections in the ascending aorta and aortic arch: a comparison between graft replacement and graft preservation techniques. Eur J Cardiothorac Surg 2016;50:660-7.
90. Preventza O, Mohamed AS, Cooley DA, et al. Homograft use in reoperative aortic root and proximal aortic surgery for endocarditis: a 12-year experience in high-risk patients. J Thorac Cardiovasc Surg 2014;148:989-94.
91. Mestres CA, Quintana E, Kopjar T, et al. Hospital Clinic Infective Endocarditis Investigators. Twenty-year experience with cryopreserved arterial allografts for vascular infections. Eur J Cardiothorac Surg 2019;55:358-65.
92. Lytle BW, Sabik JF, Blackstone EH, Svensson LG, Pettersson GB, Cosgrove DM. Reoperative cryopreserved root and ascending aorta replacement for acute aortic prosthetic valve endocarditis. Ann Thorac Surg 2002;74:S1754-7.
93. Musci M, Weng Y, Hübler M, et al. Homograft aortic root replacement in native or prosthetic active infective endocarditis: twenty-year single-center experience. J Thorac Cardiovasc Surg 2010;139:665-73.
94. Kondov S, Beyersdorf F, Rylski B, et al. Redo aortic root repair in patients with infective prosthetic endocarditis using xenopericardial solutions. Interact Cardiovasc Thorac Surg 2019;29:339-43.
95. Nakajima N, Masuda M, Ichinose M, Ando M. A new method for the treatment of graft infection in the thoracic aorta: in situ preservation. Ann Thorac Surg 1999;67:1994-6.
